These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34629715)

  • 1. Radioembolization for the Treatment of Hepatocellular Carcinoma: The Road to Personalized Dosimetry and Ablative Practice.
    De la Garza-Ramos C; Toskich BB
    Semin Intervent Radiol; 2021 Oct; 38(4):466-471. PubMed ID: 34629715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
    Toskich BB; Liu DM
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma.
    Saini A; Wallace A; Alzubaidi S; Knuttinen MG; Naidu S; Sheth R; Albadawi H; Oklu R
    J Clin Med; 2019 Jan; 8(1):. PubMed ID: 30621040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical Aspects and Practical Approach Toward Same-Day Y90 Radioembolization in the Management of Hepatocellular Carcinoma.
    Gabr A; Ali R; Al Asadi A; Mora R; Mouli S; Riaz A; Salem R; Lewandowski RJ
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):93-99. PubMed ID: 31079717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
    Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
    J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the MAA-Y90 Paradigm: The Evolution of Radioembolization Dosimetry Approaches and Scout Particles.
    Keane G; Lam M; de Jong H
    Semin Intervent Radiol; 2021 Dec; 38(5):542-553. PubMed ID: 34853500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Selection and Clinical Outcomes of Y90 in Hepatocellular Carcinoma.
    Wehrenberg-Klee E; Gandhi RT; Ganguli S
    Tech Vasc Interv Radiol; 2019 Jun; 22(2):70-73. PubMed ID: 31079713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma: A Practical Review of Evidence.
    Mourad SN; De la Garza-Ramos C; Toskich BB
    Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yttrium-90 microsphere radioembolization for hepatocellular carcinoma.
    Edeline J; Gilabert M; Garin E; Boucher E; Raoul JL
    Liver Cancer; 2015 Mar; 4(1):16-25. PubMed ID: 26020026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.
    Tong AK; Kao YH; Too CW; Chin KF; Ng DC; Chow PK
    Br J Radiol; 2016 Jun; 89(1062):20150943. PubMed ID: 26943239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yttrium-90 Radioembolization of Hepatocellular Carcinoma-Performance, Technical Advances, and Future Concepts.
    Molvar C; Lewandowski R
    Semin Intervent Radiol; 2015 Dec; 32(4):388-97. PubMed ID: 26622103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Techniques to Optimize Radioembolization Tumor Coverage.
    Fassia MK; Charalel RA
    Semin Intervent Radiol; 2024 Feb; 41(1):16-19. PubMed ID: 38495264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of Y90 radioembolization for recurrent hepatocellular carcinoma following curative resection.
    Ali R; Riaz A; Gabr A; Abouchaleh N; Mora R; Al Asadi A; Caicedo JC; Abecassis M; Katariya N; Maddur H; Kulik L; Lewandowski RJ; Salem R
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2195-2202. PubMed ID: 28812136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis.
    Facciorusso A; Bargellini I; Cela M; Cincione I; Sacco R
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32272656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial Radioembolization (TARE) Global Practice Patterns: An International Survey by the Cardiovascular and Interventional Radiology Society of Europe (CIRSE).
    Keane G; Lam M; Braat A; Bruijnen R; Kaufmann N; de Jong H; Smits M
    Cardiovasc Intervent Radiol; 2024 Sep; 47(9):1224-1236. PubMed ID: 38914769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard Radiation Dosimetry Models: What Interventional Radiologists Need to Know.
    Webster LA; Villalobos A; Majdalany BS; Bercu ZL; Gandhi RT; Kokabi N
    Semin Intervent Radiol; 2021 Oct; 38(4):405-411. PubMed ID: 34629706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution, pharmacokinetics, and organ-level dosimetry for
    Esquinas PL; Shinto A; Kamaleshwaran KK; Joseph J; Celler A
    EJNMMI Phys; 2018 Dec; 5(1):30. PubMed ID: 30523435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical Safety of Ablative Yttrium-90 Radioembolization for Hepatocellular Carcinoma as a Function of Percent Liver Treated.
    De la Garza-Ramos C; Overfield CJ; Montazeri SA; Liou H; Paz-Fumagalli R; Frey GT; McKinney JM; Ritchie CA; Devcic Z; Lewis AR; Harnois DM; Patel T; Toskich BB
    J Hepatocell Carcinoma; 2021; 8():861-870. PubMed ID: 34368021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albumin-bilirubin grade as a prognostic indicator for patients with non-hepatocellular primary and metastatic liver malignancy undergoing Yttrium-90 radioembolization using resin microspheres.
    Azar A; Devcic Z; Paz-Fumagalli R; Vidal LLC; McKinney JM; Frey G; Lewis AR; Ritchie C; Starr JS; Mody K; Toskich B
    J Gastrointest Oncol; 2020 Aug; 11(4):715-723. PubMed ID: 32953155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.
    Kennedy A; Nag S; Salem R; Murthy R; McEwan AJ; Nutting C; Benson A; Espat J; Bilbao JI; Sharma RA; Thomas JP; Coldwell D
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):13-23. PubMed ID: 17448867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.